Kunkel Lori Anne 4
4 · Oric Pharmaceuticals, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-02+35,000→ 35,000 totalExercise: $8.26Exp: 2035-01-01→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2025.